Novel insights into RB1 mutation
- PMID: 35964818
- DOI: 10.1016/j.canlet.2022.215870
Novel insights into RB1 mutation
Abstract
Since the discovery of the retinoblastoma susceptibility gene (RB1) decades ago, RB1 has been regarded as a prototype tumor suppressor gene providing a paradigm for tumor genetic research. Constant research has updated the understanding of RB1-related pathways and their impact on tumor and nontumor diseases. Mutation of RB1 gene has been observed in multiple types of malignant tumors including prostate cancer, lung cancer, breast cancer, and almost every familial and sporadic case of retinoblastoma. Even if well-known and long-investigated, the application potential of RB1 mutation has not been fully tapped. In this review, we focus on the mechanism underlying RB1 mutation during oncogenesis. Therapeutically, we have further discussed potential clinical strategies by targeting RB1-mutated cancers. The unsolved problems and prospects of RB1 mutation are also discussed.
Keywords: Mutation; RB1; Retinoblastoma; Tumorigenesis.
Copyright © 2022 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Genetics of Retinoblastoma.Asia Pac J Ophthalmol (Phila). 2016 Jul-Aug;5(4):260-4. doi: 10.1097/APO.0000000000000219. Asia Pac J Ophthalmol (Phila). 2016. PMID: 27488068 Review.
-
The RB1 Story: Characterization and Cloning of the First Tumor Suppressor Gene.Genes (Basel). 2019 Nov 1;10(11):879. doi: 10.3390/genes10110879. Genes (Basel). 2019. PMID: 31683923 Free PMC article. Review.
-
Molecular alterations in retinoblastoma beyond RB1.Exp Eye Res. 2021 Oct;211:108753. doi: 10.1016/j.exer.2021.108753. Epub 2021 Aug 31. Exp Eye Res. 2021. PMID: 34478740
-
Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients.Exp Eye Res. 2021 Apr;205:108456. doi: 10.1016/j.exer.2021.108456. Epub 2021 Jan 23. Exp Eye Res. 2021. PMID: 33493472
-
RB1 germline mutation spectrum and clinical features in patients with unilateral retinoblastomas.Ophthalmic Genet. 2021 Oct;42(5):593-599. doi: 10.1080/13816810.2021.1946703. Epub 2021 Jun 30. Ophthalmic Genet. 2021. PMID: 34190019
Cited by
-
The Use of rAAV2-RB1-Mediated Gene Therapy in Retinoblastoma.Invest Ophthalmol Vis Sci. 2023 Dec 1;64(15):31. doi: 10.1167/iovs.64.15.31. Invest Ophthalmol Vis Sci. 2023. PMID: 38133505 Free PMC article.
-
Risk of Second Tumors in Retinoblastoma Survivors after Ionizing Radiation: A Review.Cancers (Basel). 2023 Nov 9;15(22):5336. doi: 10.3390/cancers15225336. Cancers (Basel). 2023. PMID: 38001596 Free PMC article. Review.
-
Loss of Function of the Retinoblastoma Gene Affects Gap Junctional Intercellular Communication and Cell Fate in Osteoblasts.Biology (Basel). 2024 Jan 11;13(1):39. doi: 10.3390/biology13010039. Biology (Basel). 2024. PMID: 38248470 Free PMC article.
-
Genetics in ophthalmology: molecular blueprints of retinoblastoma.Hum Genomics. 2023 Sep 1;17(1):82. doi: 10.1186/s40246-023-00529-w. Hum Genomics. 2023. PMID: 37658463 Free PMC article. Review.
-
Ellagic Acid and Cancer Hallmarks: Insights from Experimental Evidence.Biomolecules. 2023 Nov 15;13(11):1653. doi: 10.3390/biom13111653. Biomolecules. 2023. PMID: 38002335 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
